Completed

New England School of Acupuncture (NESA) Acupuncture Research Collaborative

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Data Collection

Who is being recruted

Urogenital Diseases+18

+ Genital Diseases

+ Adnexal Diseases

Over 18 Years
See all eligibility criteria
How is the trial designed

Treatment Study

Phase 1
Interventional
Study Start: January 2005
See protocol details

Summary

Principal SponsorNational Center for Complementary and Integrative Health (NCCIH)
Last updated: December 11, 2025
Sourced from a government-validated database.Claim as a partner

Study start date: January 1, 2005

Actual date on which the first participant was enrolled.

This trial comprises three studies. In the first two studies, women will be randomly assigned to receive either real or sham acupuncture therapy. Study 1 will include women with various forms of cancer. White blood cell counts will be used to assess the effects of acupuncture on participants' immune responses. Study 2 will include women with unspecified pelvic pain and endometriosis; a self-report pain scale will be used to assess the effects of acupuncture on participants' symptoms. Study 3 will evaluate the validity and reliability of diagnoses made by Chinese medicine practitioners. In this study, a group of Chinese medicine practitioners will diagnose the same group of patients; consistency of the diagnoses will be evaluated.

Official TitleNew England School of Acupuncture (NESA) Acupuncture Research Collaborative 
Principal SponsorNational Center for Complementary and Integrative Health (NCCIH)
Last updated: December 11, 2025
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

50 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.


Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Female

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Urogenital DiseasesGenital DiseasesAdnexal DiseasesEndocrine System DiseasesEndocrine Gland NeoplasmsEndometriosisFemale Urogenital Diseases and Pregnancy ComplicationsGenital Diseases, FemaleGenital Neoplasms, FemaleGonadal DisordersNeoplasmsNeoplasms by SiteNeurologic ManifestationsOvarian DiseasesOvarian NeoplasmsPainUrogenital NeoplasmsUterine DiseasesUterine NeoplasmsPelvic PainFemale Urogenital Diseases

Criteria

Inclusion Criteria for Study 1: * Newly diagnosed ovarian cancer; primary peritoneal cancer; papillary serous cancer of the endometrium; or mixed mesodermal tumor of the uterus, ovary, or fallopian tube * Currently undergoing chemotherapy * Meet certain laboratory test requirements Inclusion Criteria for Study 2: Currently closed to recruitment * Diagnosed with endometriosis or unspecified pelvic pain Exclusion Criteria for Studies 1 and 2: * Use of white blood cell boosters * Prior radiotherapy with the exception of whole-breast irradiation for breast cancer * Prior myelotoxic chemotherapy * History of symptomatic cardiac or psychiatric disorder * Use of a pacemaker * Use of herbs or herbal supplements * Prior use of acupuncture * Enrollment in other research studies

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Dana Farber Cancer Institute

Boston, United StatesSee the location
CompletedOne Study Center